Goodbye Flat Biology brings together researchers who are interested in the techniques and applications of 3D culture at the cancer biology, engineering and drug development interface.
Theresa Mulholland, of ScreenIn3D, attended the event to present a poster – Microfluidic technology for oncology precision medicine.
Chemotherapy with cytotoxic and growth inhibitory drugs have played an important role in cancer therapy, used either alone or in combination with other treatment modalities such as surgery, radiation or biological therapy. Chemotherapy, in most instances, was the only alternative treatment for metastatic cancer – mainly given as drug combinations…
Innovation AveNEW is a traditional highlight of the annual SLAS Conference and Exhibition. Through this program, SLAS provides start-up companies with tremendous exposure and prestige by granting complimentary exhibit space and in-kind support that enables the company’s participation at the SLAS Annual Conference & Exhibition.
High-attrition rates during clinical development of new cancer therapies still persist. A new 3D ex vivo microfluidics platform shall now enhance cancer drug screening and early development process by creating cancer models which predict clinical outcomes with significantly increased reliability.
